NCT02339207View on ClinicalTrials.gov

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

PHASE1CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Chronic Hepatitis C
Interventions
DRUG

AL-335 matching placebo

DRUG

AL-335

Trial Locations (3)

355042

Biotrial, Rennes

Unknown

Arensia, Research Institute of Clinical Medicine, Tbilisi

Arensia, Republican Clinical Hospital, Chisinau

Sponsors
All Listed Sponsors
lead

Alios Biopharma Inc.

INDUSTRY

NCT02339207 - First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 | Biotech Hunter | Biotech Hunter